Avantor Performance Materials Names New CEO - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Avantor Performance Materials Names New CEO


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 6

Avantor Performance Materials, a manufacturer and supplier of high-performance chemistries, reported the appointment of Michael Stubblefield as CEO. Stubblefield has over 20 years of global chemical industry leadership experience. Most recently, Stubblefield served as a senior expert for the Chemicals Practice of McKinsey & Company.

In his role as CEO, Stubblefield will oversee all aspects of Avantor’s global operations in its four business areas, which include laboratory products, pharmaceuticals, electronic materials, and diagnostics. He will be based at Avantor’s corporate headquarters in Center Valley, PA. Stubblefield holds an MBA from Texas A&M University-Corpus Christi, and a Bachelor of Science degree in chemical engineering from the University of Utah.

Source: Avantor Performance Materials

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here